The financials
Wave Life Sciences Ltd. by the numbers
Wave Life Sciences Ltd. (WVE) reported revenue of $38M in Q1 2026 (quarter ended March 31, 2026), up 317% from the same quarter a year earlier. That came with net loss of $26M. For the full year FY2025, revenue was $43M (−61% year on year) and net income −$204M.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $38M | $9.2M | +317% |
| Operating income | −$31M | −$50M | n/a |
| Net income | −$26M | −$47M | n/a |
| Diluted EPS | −$0.13 | −$0.29 | n/a |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q3 2024Total $300.0K (-50%)
Category One Programs grew -99% year on year
Segment Latestquarter on quarteryear on year
- Category One Programs$300.0K$300.0KQoQ -50%year on year -99%-50%-99%